Cardioprotective Effect of Reamberin in Ischemic — Reperfusion Injury

Objective: to identify the effectiveness of the drug Reamberin in complex intensive threatment of patients with cardiac surgery in heart fibrillation and remodeling of prosthetic heart valves and plastic defects of atrial and ventricular septa. Reamberin according the following protocol: 400 ml in t...

Full description

Bibliographic Details
Main Authors: L. V. Nowicka-Usenko, A. V. Tsarev
Format: Article
Language:English
Published: Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, Russia 2016-10-01
Series:Общая реаниматология
Subjects:
Online Access:https://www.reanimatology.com/rmt/article/view/1539
_version_ 1797874191128592384
author L. V. Nowicka-Usenko
A. V. Tsarev
author_facet L. V. Nowicka-Usenko
A. V. Tsarev
author_sort L. V. Nowicka-Usenko
collection DOAJ
description Objective: to identify the effectiveness of the drug Reamberin in complex intensive threatment of patients with cardiac surgery in heart fibrillation and remodeling of prosthetic heart valves and plastic defects of atrial and ventricular septa. Reamberin according the following protocol: 400 ml in the first 6 hours of the postoperative period as an intravenous drip at a rate of 60—90 drops/min. In group 2 (control group), 26 patients received standard intensive care medication. In addition to standard clinical and laboratory tests during the study following components were quantitavile determined in blood: troponin I, lactate dehydrogenase, creatine kinase, isofractions of creatine kinaseMB, transaminases (alanine aminotransferase and aspartate aminotransferase).Results. Treatment of patients from the main group revealed the recovery of functional parametersof the myocardium, improved dynamics of cardiac enzymes and normalization of blood acid-base status.Conclusion. Inclusion in the complex intensive therapy of post#cardiac surgery of the Reamberin in patients experiencing heart fibrillation after the cardiopulmonary bypass followed by electrical defibrillation improved the clinical course of the early postoperative period and reduced the risk of complications and early mortality.
first_indexed 2024-04-10T01:28:05Z
format Article
id doaj.art-427a4a329b1b4b3ab56620695f93b97d
institution Directory Open Access Journal
issn 1813-9779
2411-7110
language English
last_indexed 2024-04-10T01:28:05Z
publishDate 2016-10-01
publisher Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, Russia
record_format Article
series Общая реаниматология
spelling doaj.art-427a4a329b1b4b3ab56620695f93b97d2023-03-13T09:32:54ZengFederal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, RussiaОбщая реаниматология1813-97792411-71102016-10-01124495610.15360/1813-9779-2016-4-49-561516Cardioprotective Effect of Reamberin in Ischemic — Reperfusion InjuryL. V. Nowicka-Usenko0A. V. Tsarev1Днепропетровская медицинская академия Минздрава УкраиныДнепропетровская медицинская академия Минздрава УкраиныObjective: to identify the effectiveness of the drug Reamberin in complex intensive threatment of patients with cardiac surgery in heart fibrillation and remodeling of prosthetic heart valves and plastic defects of atrial and ventricular septa. Reamberin according the following protocol: 400 ml in the first 6 hours of the postoperative period as an intravenous drip at a rate of 60—90 drops/min. In group 2 (control group), 26 patients received standard intensive care medication. In addition to standard clinical and laboratory tests during the study following components were quantitavile determined in blood: troponin I, lactate dehydrogenase, creatine kinase, isofractions of creatine kinaseMB, transaminases (alanine aminotransferase and aspartate aminotransferase).Results. Treatment of patients from the main group revealed the recovery of functional parametersof the myocardium, improved dynamics of cardiac enzymes and normalization of blood acid-base status.Conclusion. Inclusion in the complex intensive therapy of post#cardiac surgery of the Reamberin in patients experiencing heart fibrillation after the cardiopulmonary bypass followed by electrical defibrillation improved the clinical course of the early postoperative period and reduced the risk of complications and early mortality.https://www.reanimatology.com/rmt/article/view/1539реамберинкардиохирургияишемическиреперфузионное повреждение миокардаинтенсивная терапия
spellingShingle L. V. Nowicka-Usenko
A. V. Tsarev
Cardioprotective Effect of Reamberin in Ischemic — Reperfusion Injury
Общая реаниматология
реамберин
кардиохирургия
ишемическиреперфузионное повреждение миокарда
интенсивная терапия
title Cardioprotective Effect of Reamberin in Ischemic — Reperfusion Injury
title_full Cardioprotective Effect of Reamberin in Ischemic — Reperfusion Injury
title_fullStr Cardioprotective Effect of Reamberin in Ischemic — Reperfusion Injury
title_full_unstemmed Cardioprotective Effect of Reamberin in Ischemic — Reperfusion Injury
title_short Cardioprotective Effect of Reamberin in Ischemic — Reperfusion Injury
title_sort cardioprotective effect of reamberin in ischemic reperfusion injury
topic реамберин
кардиохирургия
ишемическиреперфузионное повреждение миокарда
интенсивная терапия
url https://www.reanimatology.com/rmt/article/view/1539
work_keys_str_mv AT lvnowickausenko cardioprotectiveeffectofreamberininischemicreperfusioninjury
AT avtsarev cardioprotectiveeffectofreamberininischemicreperfusioninjury